Table 2.
Comparison of adverse outcomes after primary and revision total shoulder arthroplasty
| Primary TSA | Revision TSA | Bivariate analysis | Multivariate analysisa | |||
|---|---|---|---|---|---|---|
| n = 10,371 | n = 496 | OR | p value | OR | p value | |
| Any adverse complication | 6.53% | 10.69% | 1.64 | < 0.001* | 1.73 | < 0.001* |
| Major adverse complications | 2.31% | 4.64% | 2.00 | 0.001* | 2.08 | 0.001* |
| Death | 0.17% | 0.40% | 2.32 | 0.244 | 2.56 | 0.211 |
| Pulmonary complications | 0.70% | 0.40% | 0.57 | 0.429 | 0.46 | 0.589 |
| DVT/PE | 0.33% | 0.40% | 1.23 | 0.775 | 1.29 | 0.729 |
| Stroke/cerebrovascular accident | 0.11% | 0.20% | 1.90 | 0.531 | 2.06 | 0.492 |
| Sepsis | 0.19% | 0.81% | 4.18 | 0.004 | 4.53 | 0.007 |
| Return to operating room | 1.07% | 2.62% | 2.45 | 0.001* | 2.44 | 0.004 |
| Minor adverse complications | 4.82% | 7.46% | 1.55 | 0.008 | 1.59 | 0.010 |
| Wound infection | 0.33% | 1.41% | 4.30 | < 0.001* | 3.45 | 0.001* |
| Urinary tract infection | 0.76% | 1.41% | 1.85 | 0.111 | 1.98 | 0.087 |
| Blood transfusion | 3.87% | 5.24% | 1.36 | 0.124 | 1.38 | 0.125 |
| Readmission | 2.87% | 4.08% | 1.42 | 0.120 | 1.45 | 0.118 |
Significant values are presented in bold
OR odds ratio, DVT/PE deep vein thrombosis/pulmonary embolism
*Significance defined as p < 0.0038 after correcting for multiple-group comparisons
aBinary logistic regression